Clearscope vs PHAGE Corporation: Revenue, Funding & Team Size Compared
Last updated
Clearscope generates $1.5M in revenue; PHAGE Corporation generates $1.5M. PHAGE Corporation and Clearscope are close to the same size by revenue. The table below compares Clearscope and PHAGE Corporation on funding, valuation, customers, team size and headquarters — every figure GetLatka has verified for each company.
| Company | ||
|---|---|---|
| Revenue | $1.5M | $1.5M |
| Valuation | Not disclosed | $12.4M |
| Team size | 14 | 7 |
| Founded | 2016 | 2018 |
| HQ | Austin, United States | New York, United States |
Want the full dataset? GetLatka tracks revenue, funding and team history for thousands of SaaS companies, with charts, growth rates and founder interviews.
Clearscope at a glance
Clearscope generates $1.5M in revenue with 14 employees, headquartered in Austin, United States.
- Revenue
- $1.5M
- Team size
- 14
- Founded
- 2016
Clearscope is the #1 content-first SEO platform that empowers marketing and editorial teams optimize their content for search intent and search engines by making it easy (and fast) to:, Identify the right keywords to incorporate to meet…
PHAGE Corporation at a glance
PHAGE Corporation generates $1.5M in revenue with 7 employees, headquartered in New York, United States.
- Revenue
- $1.5M
- Valuation
- $12.4M
- Team size
- 7
- Founded
- 2018
SaaS and Real World Data platform supporting therapeutic development
Other Clearscope alternatives
Clearscope competes with more than the companies on this page. Browse the full alternative lists to compare revenue, funding and team size across the category.
Clearscope vs PHAGE Corporation: frequently asked questions
Is Clearscope or PHAGE Corporation bigger?
PHAGE Corporation is the bigger company by revenue, at $1.5M against $1.5M for Clearscope.
How much revenue does Clearscope make?
Clearscope generates $1.5M in annual revenue with a team of 14.
How much revenue does PHAGE Corporation make?
PHAGE Corporation generates $1.5M in annual revenue with a team of 7.